capiton

About capiton

Capiton is a long-established Berlin-headquartered DACH mid-cap private equity firm with €1.6 billion of assets under management as of December 2024, founded in 1999 (current AG legal structure 2004). The firm remains a partner-owned independent platform (inhabergeführte Beteiligungsgesellschaft). Capiton has delivered approximately 18% average annual EBITDA growth across the portfolio, making it one of the longest-tenured Berlin-headquartered DACH mid-cap GPs.

Investment thesis

Capiton deploys capital through six generations of flagship funds plus AlphaPet follow-on and buy-and-build vehicles and Quantum funds, targeting mid-cap buy-out partnerships with profitable, growth-oriented DACH companies. Investment focus spans companies with €50-300 million revenue and equity tickets of €20-60 million. Sector focus spans high-tech industrials, healthcare and life sciences, business services, consumer goods and software. Geographic deployment is anchored in the DACH region (Germany, Austria, Switzerland) with selective adjacent European bolt-ons. The partner-at-eye-level approach combines with disciplined sector specialisation across multi-decade portfolio relationships.

Recent activity

Recent realised exits include healthcare IT (CymbiQ and Anovis Group, January-March 2026), industrial processing (Dec Group, February 2026), packaging (KM Packaging to ALPLA Group, 2025) and industrial components (GRITEC, October 2024). Recent acquisitions include home healthcare (SAPV Care majority stake, March 2026), pet supplements (Tierliebhaber via AlphaPet, April 2026) and pet food (Cpro Food via AlphaPet, April 2026). The platform continues active deployment across the flagship fund and AlphaPet buy-and-build platform. Detailed buyer names and multiple data available on Pro at €49/month.